Teri M Ruppenthal

Title: The Innovative Contributions of Teri M. Ruppenthal

Introduction

Teri M. Ruppenthal, based in Hedgesville, West Virginia, is a distinguished inventor recognized for her impactful contributions to the field of biomedical technology. With two patents to her name, she has demonstrated a commitment to advancing methods of detecting specific antibodies through innovative lateral flow techniques.

Latest Patents

Ruppenthal's latest patents include the "Incorporation of selective binding substances in a solid phase assay device," which discloses a method for detecting class-specific antibodies reactive with various analytes, including bacteria and allergens. This invention utilizes gold-labeled antigens that react with test samples from bodily fluids, resulting in visible colored lines on a lateral flow strip that indicate the presence of specific antibodies.

Another significant patent is the "Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays." Similar to her earlier work, this invention focuses on detecting antibodies specific to allergens through the use of gold-labeled anti-IgE antibodies. The resulting complex forms colored lines at designated test areas, allowing for quick and effective detection of allergen-specific IgE antibodies in human serum.

Career Highlights

Teri M. Ruppenthal is currently employed at Dexall Biomedical Labs, Inc., where she applies her expertise to the development of innovative diagnostic tools. Her work plays a crucial role in advancing healthcare solutions, particularly in the realm of immunology.

Collaborations

Throughout her career, Ruppenthal has collaborated with notable colleagues such as Thomas T. Hubscher and Glen M. Ford. These partnerships have facilitated the exchange of ideas and technical expertise, further enhancing the development of effective biomedical solutions.

Conclusion

Teri M. Ruppenthal stands out as a remarkable inventor whose innovative patents have made significant contributions to the field of biomedical diagnostics. Her methodologies not only enhance detection capabilities for various diseases and conditions but also underscore the importance of innovation in improving healthcare outcomes.